Ouro Fino Saude Animal Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Public

  • Employees
  • 1,114

Employees

  • Stock Symbol
  • OFSA3

Stock Symbol

  • Share Price
  • $4.80
  • (As of Friday Closing)

Ouro Fino Saude Animal General Information

Description

Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary products. The company's reportable segments are Production animals, Companion animals, and International operations. It generates maximum revenue from the Production animals segment. The product portfolio includes Anticoccidials, Antimastitics, Biological, Ectoparasiticides, Endectocides, and others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Corporate Office
  • Rodovia Anhanguera SP 330, Km 298
  • Distrito Industrial, Cravinho
  • Sao Paulo, 14140
  • Brazil
+55 (16)
Primary Industry
Other Consumer Non-Durables
Stock Exchange
BVMF
Vertical(s)
Corporate Office
  • Rodovia Anhanguera SP 330, Km 298
  • Distrito Industrial, Cravinho
  • Sao Paulo, 14140
  • Brazil
+55 (16)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ouro Fino Saude Animal Stock Performance

As of 13-Nov-2026, Ouro Fino Saude Animal’s stock price is $4.80. Its current market cap is $258M with 53.8M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.80 $4.83 $3.99 - $7.01 $258M 53.8M 4.84K $0.83

Ouro Fino Saude Animal Financials Summary

As of 30-Jun-2026, Ouro Fino Saude Animal has a trailing 12-month revenue of $258M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 316,061 276,860 186,595 307,299
Revenue 257,785 218,878 190,182 188,726
EBITDA 59,501 51,801 45,498 25,349
Net Income 44,575 39,722 24,929 (9,999)
Total Assets 311,021 285,776 224,030 263,539
Total Debt 99,849 91,909 60,692 90,146
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Ouro Fino Saude Animal Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ouro Fino Saude Animal‘s full profile, request access.

Request a free trial

Ouro Fino Saude Animal Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Ourofino SA is engaged in research, development, production and sales of medicines, vaccines and other veterinary produc
Other Consumer Non-Durables
Sao Paulo, Brazil
1,114 As of 2025

Indianapolis, IN
 

Rutherford, Australia
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Ouro Fino Saude Animal Competitors (3)

One of Ouro Fino Saude Animal’s 3 competitors is Elanco Animal Health, a Corporation company based in Indianapolis, IN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elanco Animal Health Corporation Indianapolis, IN
Jurox Corporate Backed or Acquired Rutherford, Australia
Nutreco Formerly PE-Backed Amersfoort, Netherlands
You’re viewing 3 of 3 competitors. Get the full list »

Ouro Fino Saude Animal Patents

Ouro Fino Saude Animal Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3932943-A1 Biologically active recombinant equine chorionic gonadotropin (recg) and process for obtaining same, veterinary composition and use Inactive 28-Feb-2019
EP-3932943-A4 Biologically active recombinant equine chorionic gonadotropin (recg) and process for obtaining same, veterinary composition and use Inactive 28-Feb-2019
WO-2020172728-A1 Biologically active recombinant equine chorionic gonadotropin (recg) and process for obtaining same, veterinary composition and use Inactive 28-Feb-2019
EP-3398609-A1 Process of producing a recombinant equine chorionic gonadotropin (recg), veterinary composition and use thereof Inactive 28-Dec-2015
EP-3398609-A4 Process of producing a recombinant equine chorionic gonadotropin (recg), veterinary composition and use thereof Inactive 28-Dec-2015 A61K38/24
To view Ouro Fino Saude Animal’s complete patent history, request access »

Ouro Fino Saude Animal Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ouro Fino Saude Animal Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ouro Fino Saude Animal‘s full profile, request access.

Request a free trial

Ouro Fino Saude Animal ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Pharmaceuticals

Subindustry

Rank

Percentile

To view Ouro Fino Saude Animal’s complete esg history, request access »

Ouro Fino Saude Animal FAQs

  • When was Ouro Fino Saude Animal founded?

    Ouro Fino Saude Animal was founded in 1987.

  • Where is Ouro Fino Saude Animal headquartered?

    Ouro Fino Saude Animal is headquartered in Sao Paulo, Brazil.

  • What is the size of Ouro Fino Saude Animal?

    Ouro Fino Saude Animal has 1,114 total employees.

  • What industry is Ouro Fino Saude Animal in?

    Ouro Fino Saude Animal’s primary industry is Other Consumer Non-Durables.

  • Is Ouro Fino Saude Animal a private or public company?

    Ouro Fino Saude Animal is a Public company.

  • What is Ouro Fino Saude Animal’s stock symbol?

    The ticker symbol for Ouro Fino Saude Animal is OFSA3.

  • What is the current stock price of Ouro Fino Saude Animal?

    As of 13-Nov-2026 the stock price of Ouro Fino Saude Animal is $4.80.

  • What is the current market cap of Ouro Fino Saude Animal?

    The current market capitalization of Ouro Fino Saude Animal is $258M.

  • What is Ouro Fino Saude Animal’s current revenue?

    The trailing twelve month revenue for Ouro Fino Saude Animal is $258M.

  • Who are Ouro Fino Saude Animal’s competitors?

    Elanco Animal Health, Jurox, and Nutreco are competitors of Ouro Fino Saude Animal.

  • What is Ouro Fino Saude Animal’s annual earnings per share (EPS)?

    Ouro Fino Saude Animal’s EPS for 12 months was $0.83.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process